Filed: 2/14/2025ACC: 0001420506-25-000459
📋 What this filing means
PROSIGHT MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $361.84M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$361.84M
Total AUM (reported)
46.92M
Total Shares
Allocation by class
COM$256.19M70.8%
SHS$63.54M17.6%
SPON ADR$28.19M7.8%
COM NEW$5.98M1.7%
CALL$4.86M1.3%
ORD SHS$1.50M0.4%
COMMON STOCK$1.03M0.3%
Portfolio Concentration
Top 3$82.93M22.9%
4–10$139.09M38.4%
11–25$119.54M33.0%
Rest$20.28M5.6%
Top 3 weight
22.9%
Top 10 weight
61.4%
Voting Authority Distribution
Total shares with voting rights: 46.92M
Sole
Full voting authority
46.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
GALAPAGOS NV
SOLEShares1.02M
TypeSH
Market value$28.19M
7.79%
Sole
1.02M
Shared
0.00
None
0.00
ACADIA HEALTHCARE COMPANY IN
SOLEShares692K
TypeSH
Market value$27.44M
7.58%
Sole
692K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares995K
TypeSH
Market value$27.30M
7.55%
Sole
995K
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares4.39M
TypeSH
Market value$26.74M
7.39%
Sole
4.39M
Shared
0.00
None
0.00
ABCELLERA BIOLOGICS INC
SOLEShares7.35M
TypeSH
Market value$21.54M
5.95%
Sole
7.35M
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares9.52M
TypeSH
Market value$18.93M
5.23%
Sole
9.52M
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares451.13K
TypeSH
Market value$18.65M
5.16%
Sole
451.13K
Shared
0.00
None
0.00
ICON PLC
SOLEShares85K
TypeSH
Market value$17.83M
4.93%
Sole
85K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1.50M
TypeSH
Market value$17.75M
4.90%
Sole
1.50M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares329.77K
TypeSH
Market value$17.66M
4.88%
Sole
329.77K
Shared
0.00
None
0.00
SCHRODINGER INC
SOLEShares720.50K
TypeSH
Market value$13.90M
3.84%
Sole
720.50K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$13.69M
3.78%
Sole
1.09M
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares820K
TypeSH
Market value$12.00M
3.32%
Sole
820K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.32M
TypeSH
Market value$11.54M
3.19%
Sole
1.32M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares920K
TypeSH
Market value$8.67M
2.40%
Sole
920K
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares80K
TypeSH
Market value$8.45M
2.34%
Sole
80K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares620K
TypeSH
Market value$8.20M
2.27%
Sole
620K
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares6.64M
TypeSH
Market value$8.03M
2.22%
Sole
6.64M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares305.52K
TypeSH
Market value$7.57M
2.09%
Sole
305.52K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares67K
TypeSH
Market value$5.84M
1.62%
Sole
67K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares418.12K
TypeSH
Market value$5.79M
1.60%
Sole
418.12K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares176.90K
TypeSH
Market value$4.86M
1.34%
Sole
176.90K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares3.90M
TypeSH
Market value$4.02M
1.11%
Sole
3.90M
Shared
0.00
None
0.00
HAEMONETICS CORP MASS
SOLEShares46.70K
TypeSH
Market value$3.65M
1.01%
Sole
46.70K
Shared
0.00
None
0.00
CENTENE CORP DEL
SOLEShares55K
TypeSH
Market value$3.33M
0.92%
Sole
55K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GALAPAGOS NVSOLE | SPON ADR | 1.02M | SH | $28.19M 7.79% | 1.02M | 0.00 | 0.00 |
ACADIA HEALTHCARE COMPANY INSOLE | COM | 692K | SH | $27.44M 7.58% | 692K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 995K | SH | $27.30M 7.55% | 995K | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 4.39M | SH | $26.74M 7.39% | 4.39M | 0.00 | 0.00 |
ABCELLERA BIOLOGICS INCSOLE | COM | 7.35M | SH | $21.54M 5.95% | 7.35M | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 9.52M | SH | $18.93M 5.23% | 9.52M | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 451.13K | SH | $18.65M 5.16% | 451.13K | 0.00 | 0.00 |
ICON PLCSOLE | SHS | 85K | SH | $17.83M 4.93% | 85K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 1.50M | SH | $17.75M 4.90% | 1.50M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 329.77K | SH | $17.66M 4.88% | 329.77K | 0.00 | 0.00 |
SCHRODINGER INCSOLE | COM | 720.50K | SH | $13.90M 3.84% | 720.50K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $13.69M 3.78% | 1.09M | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 820K | SH | $12.00M 3.32% | 820K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 1.32M | SH | $11.54M 3.19% | 1.32M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 920K | SH | $8.67M 2.40% | 920K | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 80K | SH | $8.45M 2.34% | 80K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 620K | SH | $8.20M 2.27% | 620K | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 6.64M | SH | $8.03M 2.22% | 6.64M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 305.52K | SH | $7.57M 2.09% | 305.52K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 67K | SH | $5.84M 1.62% | 67K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 418.12K | SH | $5.79M 1.60% | 418.12K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | CALL | 176.90K | SH | $4.86M 1.34% | 176.90K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 3.90M | SH | $4.02M 1.11% | 3.90M | 0.00 | 0.00 |
HAEMONETICS CORP MASSSOLE | COM | 46.70K | SH | $3.65M 1.01% | 46.70K | 0.00 | 0.00 |
CENTENE CORP DELSOLE | COM | 55K | SH | $3.33M 0.92% | 55K | 0.00 | 0.00 |
Page 1 of 2